NIH AIDS Reagent Program品牌介绍

浏览量：1705

NIH AIDS Reagent Program

品牌简介

美国国家过敏与传染病研究所（NIAID）艾滋病分部（DAIDS）支持校外基础和应用研究，以控制和预防由HIV和其他传染源引起的疾病。研究人员开发和评估治疗、疫苗和诊断，以完成NIAID的任务。基础和临床前研究中一个重要的限速步骤是高质量、经认证的研究材料的识别和可用性。为了满足这一需求，NIAID支持HIV和其他传染病试剂计划（NIH HIV试剂计划或NIH HRP），以前称为NIH AIDS试剂计划，现在称为NIH HIV试剂计划，是一个广泛的传染源和病原体、生物材料、，以及分发给科学界的化学品。自1988年成立以来，该项目已从一个小型的研究材料库发展为向艾滋病毒/艾滋病研究界提供3000多种关键产品。NIH HIV试剂项目向65个国家的3200多名合格调查人员提供这些材料。

The National Institute of Allergy and Infectious Diseases (NIAID), Division of AIDS (DAIDS) supports extramural basic and applied research to control and prevent diseases caused by HIV and other infectious agents. Through research grants and contracts, investigators develop and evaluate therapeutics, vaccines, and diagnostics to accomplish the mission of NIAID. An important rate-limiting step in basic and preclinical research is the identification and availability of high quality, authenticated research materials. To address this need, NIAID supports the Reagent Program for HIV and Other Infectious Diseases (NIH HIV Reagent Program or NIH HRP), previously known as the NIH AIDS Reagent Program, now the NIH HIV Reagent Program that serves as a central resource for a wide range of infectious agents and pathogens, biological materials, and chemicals for distribution to the scientific community. Since established in 1988, the program has evolved from a small bank of research materials, to offering over 3,000 critical products to the HIV/AIDS research community. The NIH HIV Reagent Program provides these materials to over 3,200 qualified investigators located in 65 countries.

In addition to supplying the HIV/AIDS community with research materials, the NIH HIV Reagent Program encourages and supports the deposit of materials from researchers and institutions. Depositing materials with the NIH HIV Reagent Program has many advantages to the researcher and the research community including secure storage, community access and distribution; all while protecting the intellectual property rights of the depositor. The NIH HIV Reagent Program will be maintained as a resource for researchers as long as there is need. Your deposit into the NIH HIV Reagent Program is a long term investment to aid future research.

The NIH HIV Reagent Program has been managed under contract by American Type Culture Collection (ATCC) since 2020. ATCC shall maintain the NIH HIV Reagent Program through identification, acquisition, production, receipt, storage, maintenance, distribution and disposal of biological and chemical research organisms and materials for HIV and other infectious diseases for use in basic and translational research. ATCC shall also provide support for quality control and characterization of reagents, technology transfer, and execution of Material Transfer Agreements prior to release of reagents to the community.

Main product